Invesaro

Stocks Health care NRC

NASDAQ · Health care

Nrc Health (NRC)

Nrc Health brought in $143.8M of revenue over the twelve months to September 30, 2026, up 3.4% from a year earlier. Net income was $6.1M, a net margin of 4.3%. Operating cash flow minus capital spending left $15.7M of free cash flow in fiscal 2025. At September 30, 2026 it held $3.6M in cash against $102.9M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.

Free, no password. An email when NRC files with the SEC.

Price
$26.67
+3.13% on the day · November 9, 2026
52-week range $11.74 to $27.41
Market cap
$589.9M
Revenue (last 12 months)
$143.8M
+3.4% year on year
Net margin
4.3%
P/E
0.5
on FY2025 diluted EPS

Key facts about Nrc Health

Net worth
Nrc Health has a market value (market cap) of $589.9M at the latest share price, and shareholders' equity of -$9.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $137.4M (-4.0% year on year), with net income of $11.3M. Over the 12 months to September 30, 2026: revenue $143.8M, net income $6.1M.
Cash flow
In fiscal 2025 operations brought in $26.5M of cash; after $10.7M of capital spending, free cash flow was $15.7M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Nrc Health's next report is expected around February 2, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
Nrc Health declared dividends of $0.52 per share in fiscal 2025, a yield of 1.95% at the current price.

What Nrc Health does

Nrc Health is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker NRC.

Revenue and profit by year

Revenue
FY18: $119.7M $119.7M FY18FY19: $128M $128M FY19FY20: $133.3M $133.3M FY20FY21: $148M $148M FY21FY22: $151.6M $151.6M FY22FY23: $148.6M $148.6M FY23FY24: $143.1M $143.1M FY24FY25: $137.4M $137.4M FY25
Net income
FY18: $30M $30M FY18FY19: $32.4M $32.4M FY19FY20: $37.2M $37.2M FY20FY21: $37.4M $37.4M FY21FY22: $31.8M $31.8M FY22FY23: $31M $31M FY23FY24: $24.8M $24.8M FY24FY25: $11.3M $11.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$137.4M$22.6M$11.3M$50.00$15.7M
2024$143.1M$35.2M$24.8M$1.04$19.2M
2023$148.6M$40M$31M$1.25$22.3M
2022$151.6M$46.5M$31.8M$1.27$26.4M
2021$148M$50.3M$37.4M$1.46$40.8M
2020$133.3M$42.7M$37.2M$1.45$36.7M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 2, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 3, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where NRC ranks in Health care

Revenue$137.4M
#303 of 751 in Health care · Top 40%
Revenue growth-4.0%
#446 of 532 in Health care · Bottom 16%
Net margin8.2%
#131 of 544 in Health care · Top 24%
Free cash flow margin11.5%
#116 of 490 in Health care · Top 24%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Nrc Health declared $0.52 per share in fiscal 2025. At the current price that is a yield of 1.95%. It paid out $11M in cash dividends, 97% of its net income.

Fiscal yearPer sharePaid outOf profit
2025$0.52$11M97%
2024$0.48$11.5M46%
2023$1.48$36.4M117%
2022$0.84$21M66%
2021$0.48$9.2M24%
2020$0.21$10.5M28%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Nrc Health has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 6, 2026
  2. November 4, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 11% to $38.4M versus the same quarter last year; diluted EPS $0.21 versus $0.18.
  3. October 27, 2026
  4. October 19, 2026
  5. August 13, 2026
  6. August 11, 2026
  7. August 4, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 4% to $35.4M versus the same quarter last year; diluted EPS -$0.15 versus -$0.01.
  8. July 28, 2026
  9. June 29, 2026
  10. June 12, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 25, 2026. Insider transactions on SEC

What is NRC worth? A DCF from its reported cash flow

Insider trades

What the people running Nrc Health did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
June 23, 2026 Wheeler Penny AnnDirector Received as pay 7,697 - - Form 4
June 23, 2026 Nunnelly John NDirector Received as pay 7,697 - - Form 4
June 23, 2026 Lockhart Stephen HDirector Received as pay 7,697 - - Form 4
June 23, 2026 Bhandari ParulDirector Received as pay 7,697 - - Form 4
June 23, 2026 Berwick Donald MDirector Received as pay 7,697 - - Form 4
March 12, 2026 Rau Jason RussellExecutive Vice President Received as pay 60,000 - - Form 4
February 17, 2026 Harrison Shane REVP & Chief Financial Officer Boughtindirect 8,000 $12.27 $98.2K Form 4
January 5, 2026 Burik DavidEVP, Strategic Insights Received as pay 100,000 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NRC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Beans Patrick E.13D, may seek influence with 4 related filers 47.2% 10,018,016 November 6, 2026
Kayne Anderson Rudnick Investment Management, LLC13G, passive with 2 related filers 9% 2,030,492 August 13, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 124 managers reported a position.

HolderSharesValueChange on quarter
Kayne Anderson Rudnick Investment Management LLC2,030,492$43.8M-605,863
BlackRock, Inc.1,061,355$22.9M+85,500
Morgan Stanley859,269$18.5M-142,611
Vanguard Capital Management LLC666,554$14.4M+3,717
Dimensional Fund Advisors LP491,228$10.6M+1,488
Willis Investment Counsel434,785$9.4M+210,147
Geode Capital Management, LLC420,056$9.1M+26,209
Farmers & Merchants Investments Inc330,649$7.1M+330,549
Renaissance Technologies LLC325,384$7M-15,400
State Street Corp298,384$6.5M-2,364
Heartland Advisors Inc300,000$6.5M+62,853
Bank of New York Mellon Corp252,235$5.4M+1,528
Northern Trust Corp238,243$5.1M-17,358
Hotchkis & Wiley Capital Management LLC187,920$4.1M-98,920
Wells Fargo & Company179,623$3.9M+62,727
Aqr Capital Management LLC122,206$2.6M-49,641
Charles Schwab Investment Management Inc113,312$2.4M+938
Northwest & Ethical Investments L.P.102,370$2.2M-26,830
Vanguard Fiduciary Trust Co97,200$2.1M+4,046
Goldman Sachs Group Inc96,776$2.1M+14,084

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

10 insiders reported holding 550,552 shares in total, about $14.7M at the last price.

HolderSharesAs of
Harrison Shane REVP & Chief Financial Officer 158,7298,000 held indirectly February 17, 2026
Hrdy HelenEVP & Chief Operating Officer 140,518 December 15, 2025
Burik DavidEVP, Strategic Insights 100,000 January 5, 2026
Rau Jason RussellExecutive Vice President 60,000 March 12, 2026
Nunnelly John NDirector 40,363 June 23, 2026
Hays Michael D.Chairman, Director 20,154 January 5, 2026
Wheeler Penny AnnDirector 7,697 June 23, 2026
Bhandari ParulDirector 7,697 June 23, 2026
Lockhart Stephen HDirector 7,697 June 23, 2026
Berwick Donald MDirector 7,697 June 23, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NRC

What does Nrc Health do?

Nrc Health is a company in the Health care sector, listed on NASDAQ as NRC. Its shares trade on NASDAQ under the ticker NRC.

What is Nrc Health's net worth?

Nrc Health has a market value (market cap) of $589.9M at the latest share price, and shareholders' equity of -$9.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Nrc Health profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $6.1M on revenue of $143.8M, a net margin of 4.3%.

How much revenue does Nrc Health make?

Over the twelve months to September 30, 2026 Nrc Health reported revenue of $143.8M. That is 3.4% more than a year earlier.

When did Nrc Health last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the activist stake changed from November 6, 2026.

When is Nrc Health's next earnings report?

Nrc Health's next report is expected around February 2, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Does Nrc Health pay a dividend?

Yes. Nrc Health declared dividends of $0.52 per share in fiscal 2025, a yield of 1.95% at the current price.

Similar companies

Compare NRC with

Compare NRC with any company

Follow NRC

Get an email when Nrc Health files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when NRC files with the SEC.

Where the numbers come from

Financial figures are the values Nrc Health tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.